These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36787498)
1. New Postmortem Perspective on Emerging SARS-CoV-2 Variants of Concern, Germany. Heinrich F; Huter T; Mertens S; Lange P; Vering J; Heinemann A; Nörz DS; Hoffmann A; Aepfelbacher M; Ondruschka B; Krasemann S; Lütgehetmann M Emerg Infect Dis; 2023 Mar; 29(3):652-656. PubMed ID: 36787498 [TBL] [Abstract][Full Text] [Related]
2. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds. Lee BU Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724 [TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods. Shoji K; Tsuzuki S; Akiyama T; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Yamada M; Ozawa N; Yamaguchi K; Miyairi I; Ohmagari N J Infect Chemother; 2023 Jan; 29(1):33-38. PubMed ID: 36103949 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Variants of Concern. Choi JY; Smith DM Yonsei Med J; 2021 Nov; 62(11):961-968. PubMed ID: 34672129 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235 [TBL] [Abstract][Full Text] [Related]
6. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2. Parums DV Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166 [TBL] [Abstract][Full Text] [Related]
7. RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants. de Michelena P; Torres I; Ferrando EC; Olea B; González-Candelas F; Sánchez G; Navarro D Clin Microbiol Infect; 2023 Feb; 29(2):256.e1-256.e4. PubMed ID: 36115649 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern. Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH Elife; 2022 Feb; 11():. PubMed ID: 35191378 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA. Keyel AC; Russell A; Plitnick J; Rowlands JV; Lamson DM; Rosenberg E; St George K Emerg Infect Dis; 2022 Oct; 28(10):1990-1998. PubMed ID: 36048774 [TBL] [Abstract][Full Text] [Related]
10. Survivability of Delta and Omicron variants of SARS-CoV-2 in wastewater. Sherchan SP; Thakali O; Ikner LA; Gerba C; Haramoto E Water Res; 2023 Nov; 246():120644. PubMed ID: 37844338 [TBL] [Abstract][Full Text] [Related]
11. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study. Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551 [TBL] [Abstract][Full Text] [Related]